| Abstrakt: |
Keywords: Antiplatelet Agents; Clopidogrel Therapy; Coagulation Modifiers; Drugs and Therapies; Fibrinolytic Agents; Health and Medicine; Hematologic Diseases and Conditions; Hemic and Lymphatic Diseases and Conditions; Pancytopenia; Pharmaceuticals; Platelet Aggregation Inhibitors EN Antiplatelet Agents Clopidogrel Therapy Coagulation Modifiers Drugs and Therapies Fibrinolytic Agents Health and Medicine Hematologic Diseases and Conditions Hemic and Lymphatic Diseases and Conditions Pancytopenia Pharmaceuticals Platelet Aggregation Inhibitors 372 372 1 10/24/23 20231026 NES 231026 2023 OCT 26 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Researchers detail new data in pancytopenia. Some rare cases of clopidogrel-induced pancytopenia are described in scientific literature, therefore, after excluding infectious, vitamin deficiencies, and autoimmune causes, we modified the antiplatelet therapy by replacing clopidogrel with ticagrelor, obtaining complete leukocyte recovery within a few days." Keywords for this news article include: Department of Internal Medicine, Antiplatelet Agents, Pharmaceuticals, Pancytopenia, Clopidogrel Therapy, Drugs and Therapies, Fibrinolytic Agents, Health and Medicine, Coagulation Modifiers, Platelet Aggregation Inhibitors, Hematologic Diseases and Conditions, Hemic and Lymphatic Diseases and Conditions. [Extracted from the article] |
